Clinical trial · Interventional
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors: A Randomized Controlled Trial
NCT05257785CI-TRIAL-00075774Lymfit_RCTunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized control trial seeks to determine whether a tailored and supervised exercise program adopting mobile-health technology will be able to improve fitness and quality of life among lymphoma survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivors | — | UNRESOLVED | — |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Lymfit exercise intervention | Behavioral | — | UNRESOLVED |
| Waitlist control | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Lymfit exercise intervention
- description
- Participants randomized to the intervention group will be allocated a pre-registered Fitbit, a personalized exercise prescription designed by the kinesiologist, and 12 weeks of supervision by the kinesiologist.
- interventionNames
- Behavioral: Lymfit exercise intervention
- type
- OTHER
- label
- Waitlist control
- description
- Participants will receive the exact same Lymfit exercise intervention 3 months after they consent to participate in the study.
- interventionNames
- Behavioral: Waitlist control
Primary outcomes (1)
- measure
- Change of the exercise guideline as determined by comparing the active minutes captured in the Fitbit
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: 1. newly diagnosed lymphoma patients who received an initial diagnosis at the age of age 18-39, 2. approved by their hematologist as having no contra-indications to vigorous exercise, 3. receiving or has received chemotherapy with curative intent within the past 6 months, 4. own a cellular phone that is able to download the Fitbit app and to complete the study questionnaires online in either French or English, and 5. has an Internet connection at home that supports participation in coaching sessions via videoconferencing (zoom). Exclusion Criteria: 1. The patient has contra-indications to vigorous exercise, 2. the patient doesn't want to wear a fitness tracker due to various concerns (as no Fitbit data could be collected).
References
Publications (0)
Data not yet available
No reference posted for this study.